| |
| |
 |
The Vision of a
Disease Free Future |
|
|
| Overview > Alliances |
| Alliances |
| |
Bharat Biotech
International Limited partners with some of the world's best
institutions in realising its mission.
- All India Institute of Medical Sciences (AIIMS), New Delhi,
India
- Centers for Disease Control & Prevention (CDC),
Atlanta, USA
- Department of Biotechnology (DBT), Government of India
- Department of Science & Technology (DST), Government
of India
- Indian Institute of Science, Bangalore (IISc), India
- Institute of Genomics and Integrative Biology (IGIB), New
Delhi, India
- International Center for Genetic Engineering &
Biotechnology (ICGEB), New Delhi, India
- Jawaharlal Nehru Centre for Advanced Scientific
Research, Bangalore, India
- National Institute of Allergy and Infectious
Diseases, Washington DC, USA
- National Institute of Health (NIH), Washington DC, USA
- National Institute of Virology (NIV), Pune, India
- Stanford University, School of Medicine
BBIL also has the unique distinction of
receiving collaborative research and product development
grants from renowned institutions such as:
- Department of Biotechnology, Government of India, Rotavirus and Malaria Vaccine Projects.
- PATH's Advancing Rotavirus Vaccine Development (ARVAC) project - Rotavirus Vaccine Development.
- The PATH Malaria Vaccine Initiative (MVI) - Malaria Vaccine Development - Plasmodium Vivax.
- European Malasia Vaccine Initiative - Plasmodium Falciparum through International Center for Genetic Engineering & Biotechnology.
- Department of Science & Technology, Government of India
- Spread Program - World Bank
These strategic alliances have helped
us in achieving our vision to be a pioneering R&D and
production-based corporate. |
| I. Technology Agreements of
Government funded Projects |
|
Centre for Biochemical
Technology, New Delhi |
|
Technology Transfer
Agreement EGF, Lysostaphin
Staphylokinase |
|
Department of Science & Technology and Centre
for Biochemical Technology,
New Delhi |
|
Joint Development of VEGF |
|
Department of Science & Technology and
Indian Institute of Science,
Bangalore |
|
Joint Development of Third Generation Hep B Vaccine |
|
Council of Scientific & Ind Research and
Agreement of Human Centre for Biochemical Technology,
New Delhi |
|
Technology Transfer Pro - Insulin |
|
National Institute of Virology, Pune |
|
Transfer of Technology of Hepatitis A |
|
D S T, RRL Jammu & Indian Institute of Chemical
Technology, Kolkata |
|
Development of Immunoadjuvants |
|
Department of Science & Technology JNCASR -
Bangalore Diagnostic Kits |
|
Development of HIVI & HIV II |
|
| II. Marketing/Co-Marketing
Agreements |
|
Intas Pharmaceuticals Ltd
Ahmedabad |
|
International Marketing Agreement |
|
Intas Pharmaceuticals Ltd Ahmedabad |
|
Indian Marketing Agreement |
|
Wockhardt Limited |
|
Marketing Agreement for Typhoid & Rabies Vaccine |
|
Unichem Laboratories Ltd |
|
Strategic Marketing Alliance Agreement |
|
Nicholas Piramal India Ltd |
|
Marketing Agreement of Streptokinase |
|
Lupin Limited |
|
Marketing Agreement of rhEGF |
|
Hindustan Latex Ltd |
|
Marketing Agreement of Hepatitis-B & Typhoid Vaccine |
|
| III. Contract Manufacturing
Agreements |
|
Wyeth
Lederle, USA |
|
HibTITER Haemophilus
Influenzae b conjugate Vaccine) for Indian &
regulated markets-Korea |
|
Agenix Inc, USA |
|
Human Lactoferrin |
|
|
|
